Aluminium bromatum

Product NDC: 63545-839
Requested package NDC: 63545-839-01
11-digit product format: 635450839
Labeler code: 63545
Product ID: 63545-839_9c5bce1d-e166-5034-e053-2995a90ac1d1
Type: HUMAN OTC DRUG
Nonproprietary name: Aluminium bromatum
Dosage form: PELLET
Route: ORAL
Labeler: Hahnemann Laboratories, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2020-01-17
Marketing end: 0000-00-00
Substance: ALUMINUM BROMIDE
Active strength: 1 [hp_M]/1
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.

Historic NDC status page 1 of 1 · 12 matching rows.

Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63545-839	63545-839-01	I	Inactivated by FDA	excluded / ndc_excluded.zip	`bd6a592717d7…`	`303034d00443…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63545-839-01	2022-01-28	C162847	48780-1	d6a99b39-d38b-a426-e053-dadaa90af4c2	9c5bce1d-e165-5034-e053-2995a90ac1d1
63545-839-02	2022-01-28	C162847	48780-1	d6a99b39-d38b-a426-e053-dadaa90af4c2	9c5bce1d-e165-5034-e053-2995a90ac1d1
63545-839-03	2022-01-28	C162847	48780-1	d6a99b39-d38b-a426-e053-dadaa90af4c2	9c5bce1d-e165-5034-e053-2995a90ac1d1
63545-839-04	2022-01-28	C162847	48780-1	d6a99b39-d38b-a426-e053-dadaa90af4c2	9c5bce1d-e165-5034-e053-2995a90ac1d1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63545-839-01	Aluminium bromatum	200 in 1 VIAL, GLASS	PELLET	200	1
63545-839-02	Aluminium bromatum	500 in 1 VIAL, GLASS	PELLET	500	1
63545-839-03	Aluminium bromatum	3000 in 1 BOTTLE, GLASS	PELLET	3000	1
63545-839-04	Aluminium bromatum	10000 in 1 BOTTLE, GLASS	PELLET	10000	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63545-839	ALUMINIUM BROMATUM PELLET [HAHNEMANN LABORATORIES, INC.]	1	Legacy NDC, 4 package rows	20200118_9c5bce1d-e165-5034-e053-2995a90ac1d1.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
IY20HBK5LK	ALUMINUM BROMIDE	7727-15-3	ALUMINUM BROMIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63545-839-01	63545083901	200 PELLET in 1 VIAL, GLASS (63545-839-01)	200 pellet	2020-01-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Aluminium bromatum - Hahnemann Laboratories, Inc.	Hahnemann Laboratories, Inc.	2020-01-17	HUMAN OTC DRUG LABEL	1